An early Moderna COVID‑19 trial has resurfaced six years on, amid ongoing debate over vaccine risks, guidance and public trust.

Six years ago this month, New York declared a state of emergency due to covid-19. With the pandemic, the use of mRNA technology for vaccines became more mainstream. News10's Valerie Wencis spoke to ...

The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.

Add Yahoo as a preferred source to see more of our stories on Google. With a little help, your immune cells can be potent tumor killers. Steve Gschmeissner/Science Photo Library via Getty Images The ...

In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general ...

Some vaccine advisers under Robert F. Kennedy Jr sought to potentially stop recommending mRNA shots, but that plan is no ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

COVID vaccination during pregnancy protects infants from hospitalization during their first 6 months of life. Published in ...

ALBANY, NY (News10) – Six years ago this month, New York declared a state of emergency due to covid-19. With the pandemic, the use of mRNA technology for vaccines became more mainstream. At UAlbany, ...